Koneru Suchitra MD - Buffalo, New York 14221

Koneru Suchitra MD is categorized under Internal Medicine Doctors in Buffalo, NY .

Business Name: Koneru Suchitra MD
Contact Person: Suchitra Koneru
Address: 6333 Main St # 1, Buffalo, New York 14221
Phone Number: (716) 447-7106
Website Address: chsbuffalo.org
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Internal Med Id Associates LLC - Buffalo, NY 14221
Gomez Jorge MD - Buffalo, NY 14221
Liu-Helm Aries MD - Buffalo, NY 14221
Synergy Bariatrics P C - Buffalo, NY 14221
Waffner Eric MD - Buffalo, NY 14221
Thomas S Branigan Md - Buffalo, NY 14221
Loghmanee Fazlollah MD - Buffalo, NY 14221
Pleskow Sanford R MD - Buffalo, NY 14221
Paul Hart Md - Buffalo, NY 14221
Hughes III Thomas F MD - Buffalo, NY 14221
Balon Walter A MD - Buffalo, NY 14221
Hermann Thomas R MD - Buffalo, NY 14221
Ecva - Buffalo, NY 14221
LA Point Paul J DO - Buffalo, NY 14221
Benjamin G Rueda - Buffalo, NY 14221
Falcone Joseph P DO - Buffalo, NY 14221
G Pec Global Inc - Buffalo, NY 14221
Purizhansky Polina MD - Buffalo, NY 14221

The company Koneru Suchitra MD provides B2C services in the form of Internal Medicine Doctors from its single location in New York. 1 to 4 employees work for Koneru Suchitra MD, and the business now earns $500.000 to $999.999 per annum.

Koneru Suchitra MD was launched in 2011 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Koneru Suchitra MD, please call Suchitra Koneru with the phone number (716) 447-7106 or visit its single location at 6333 Main St # 1 in Buffalo, New York 14221.

The location of the single location can also be found using the coordinates 42.96612,-78.71665. Read more details about this business on the webpage chsbuffalo.org or follow the company’s social media accounts, on Twitter and on Facebook.